Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Why Gold is Attractive for Private Equity
39:49 - Berwin Leighton Paisner Partner Alexander Keepin discusses the outlook for mining and his subsequent investing strategy. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.” (Source: Bloomberg)
  • Greek Stocks Resume Trading
  • China Growth: Is 7% Still a Possibility?
  • Making the Case for a U.S. Rate Hike in December